CAPITAL FUND MANAGEMENT S.A. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPITAL FUND MANAGEMENT S.A. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,247,224
+111.8%
160,518
+163.8%
0.00%
+100.0%
Q2 2023$588,931
+119.2%
60,840
+148.2%
0.00%
+100.0%
Q1 2023$268,618
-100.0%
24,509
-87.1%
0.00%
-90.9%
Q3 2022$1,429,582,000
+0.4%
190,104
+34.1%
0.01%
-15.4%
Q2 2022$1,424,527,000
-19.2%
141,744
-0.4%
0.01%
-7.1%
Q1 2022$1,762,293,000142,3500.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders